This article updates the Heart Failure Association of the European Society of Cardiology
(ESC) 2007 classification of advanced heart failure and describes new diagnostic and …

Background The Interagency Registry for Mechanically Assisted Circulatory Support
(INTERMACS) database now includes> 20,000 patients from> 180 hospitals. Methods The …

Importance Although durable left ventricular assist device (LVAD) therapy has emerged as
an important treatment option for patients with advanced heart failure refractory to …

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for
patients with severe heart failure. Different devices are available, and many—sometimes …

Background Mechanical circulatory support with a left ventricular assist device (LVAD) is an
established treatment for patients with advanced heart failure. We compared a newer LVAD …

Background Continuous-flow left ventricular assist systems increase the rate of survival
among patients with advanced heart failure but are associated with the development of …

The seventh annual report of the Interagency Registry for Mechanically Assisted Circulatory
Support (INTERMACS) summarizes the first 9 years of patient enrollment. The Registry …

Cardiac arrest systems of care are successfully coordinating community, emergency medical
services, and hospital efforts to improve the process of care for patients who have had a …

Heart failure is a global problem with an estimated prevalence of 38 million patients
worldwide, a number that is increasing with the ageing of the population. It is the most …

Despite improvements in pharmacological therapy and pacing, prognosis in advanced heart
failure (HF) remains poor, with a 1‐year mortality of 25–50%. While heart transplantation …